Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Unternehmen

EFV / SNB: Neue Eidgenössische Anleihen » Report
DKSH Management AG: DKSH Achieves Industry-Leading Sustainability Rating from ISS ESG 2025 » Report
Kudelski Group : NAGRAVISION Highlights the Future of Streaming at IBC 2025 » Report
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD) » Report
Meyer Burger Technology AG: Meyer Burger announces SIX ruling on delisting of its shares » Report
Meyer Burger gibt SIX-Verfügung zur Dekotierung ihrer Aktien bekannt » Report
The Adecco Group and Microsoft renew strategic collaboration to drive the future of work » Report
SIX: Meyer Burger wird dekotiert - Handel bleibt suspendiert
Logitech - 4 (Statement of Changes in Beneficial Ownership) SEC Filing » Report
Indirect Property Market Weekly - J. Safra Sarasin - 08. September 2025 » Report
Alcon - Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025 » Report
AEVIS VICTORIA SA – Strong growth in revenue and consolidated results in the first half of 2025 » Report
AEVIS VICTORIA SA – Chiffre d’affaires et résultats consolidés en forte hausse au 1er semestre 2025 » Report
AEVIS VICTORIA SA – Starkes Wachstum bei Umsatz und Konzernergebnis im ersten Halbjahr 2025 » Report
Medacta Group SA reports surge in adjusted EBITDA margin to 29.6% in constant currency in H1 2025 » Report
Swiss Re Ltd: Holistic approach needed to maintain resilience in a complex risk landscape » Report
Swiss Re Ltd: Ganzheitlicher Ansatz erforderlich, um Widerstandsfähigkeit trotz komplexer Risiken beizubehalten » Report
Global property and casualty insurance market has increased efficiency, capacity and resilience, finds Swiss Re Institute » Report
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues » Report
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP) » Report